Ponesimod 7 MG Oral Tablet — RxCUI 2532339
RxNorm drug concept · Semantic clinical drug
RxCUI 2532339
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2532339
Official namePonesimod 7 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ponesimod: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Ponvory isn't a cure for MS, but it's a real treatment that can help control it. It's approved to treat relapsing forms of MS — meaning types where you have flare-ups (relapses) of...
- What exactly is Ponvory treating — is it curing my MS?
- That step-up schedule — called titration — is there to protect your heart. Ponvory can temporarily slow your heart rate, especially when you first start it. By gradually increasing...
- Why do I have to take so many different doses at the start instead of just jumping to my regular dose?
🕸️ Concept Web — How Ponesimod 7 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ponesimod 7 MG Oral Tablet
RxCUI 2532339 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ponesimod
2532300IN
-
Ponesimod
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Ponvory
2532306BN
-
Ponvory
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ponesimod Oral Tablet
2532304SCDF -
Ponesimod Oral Product
2532302SCDG -
Ponesimod Pill
2532303SCDG -
Ponesimod Oral Tablet [Ponvory]
2532308SBDF -
Ponvory Oral Product
2532309SBDG -
Ponvory Pill
2532310SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Ponesimod Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ponesimod 7 MG
2532338SCDC -
Ponesimod 7 MG Oral Tablet [Ponvory]
2532341SBD -
Ponesimod 7 MG [Ponvory]
2532340SBDC
-
Ponesimod 7 MG
-
Packs 2
Fixed collections of drugs packaged and sold together, like dose packs.
-
{3 (ponesimod 10 MG Oral Tablet [Ponvory]) / 2 (ponesimod 2 MG Oral Tablet [Ponvory]) / 2 (ponesimod 3 MG Oral Tablet [Ponvory]) / 2 (ponesimod 4 MG Oral Tablet [Ponvory]) / 1 (ponesimod 5 MG Oral Tablet [Ponvory]) / 1 (ponesimod 6 MG Oral Tablet [Ponvory]) / 1 (ponesimod 7 MG Oral Tablet [Ponvory]) / 1 (ponesimod 8 MG Oral Tablet [Ponvory]) / 1 (ponesimod 9 MG Oral Tablet [Ponvory]) } Pack [Ponvory 14 Day]
2532351BPCK -
{3 (ponesimod 10 MG Oral Tablet) / 2 (ponesimod 2 MG Oral Tablet) / 2 (ponesimod 3 MG Oral Tablet) / 2 (ponesimod 4 MG Oral Tablet) / 1 (ponesimod 5 MG Oral Tablet) / 1 (ponesimod 6 MG Oral Tablet) / 1 (ponesimod 7 MG Oral Tablet) / 1 (ponesimod 8 MG Oral Tablet) / 1 (ponesimod 9 MG Oral Tablet) } Pack
2532350GPCK
-
{3 (ponesimod 10 MG Oral Tablet [Ponvory]) / 2 (ponesimod 2 MG Oral Tablet [Ponvory]) / 2 (ponesimod 3 MG Oral Tablet [Ponvory]) / 2 (ponesimod 4 MG Oral Tablet [Ponvory]) / 1 (ponesimod 5 MG Oral Tablet [Ponvory]) / 1 (ponesimod 6 MG Oral Tablet [Ponvory]) / 1 (ponesimod 7 MG Oral Tablet [Ponvory]) / 1 (ponesimod 8 MG Oral Tablet [Ponvory]) / 1 (ponesimod 9 MG Oral Tablet [Ponvory]) } Pack [Ponvory 14 Day]
Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{3 (ponesimod 10 MG Oral Tablet) / 2 (ponesimod 2 MG Oral Tablet) / 2 (ponesimod 3 MG Oral Tablet) / 2 (ponesimod 4 MG Oral Tablet) / 1 (ponesimod 5 MG Oral Tablet) / 1 (ponesimod 6 MG Oral Tablet) / 1 (ponesimod 7 MG Oral Tablet) / 1 (ponesimod 8 MG Oral Tablet) / 1 (ponesimod 9 MG Oral Tablet) } Pack
GPCK · 2532350 -
Ponesimod 7 MG
SCDC · 2532338 -
Ponesimod Oral Tablet
SCDF · 2532304 -
Ponesimod Oral Product
SCDG · 2532302 -
Ponesimod Pill
SCDG · 2532303
Brand-Name Concepts
-
Ponesimod 7 MG Oral Tablet [Ponvory]
SBD · 2532341 -
{3 (ponesimod 10 MG Oral Tablet [Ponvory]) / 2 (ponesimod 2 MG Oral Tablet [Ponvory]) / 2 (ponesimod 3 MG Oral Tablet [Ponvory]) / 2 (ponesimod 4 MG Oral Tablet [Ponvory]) / 1 (ponesimod 5 MG Oral Tablet [Ponvory]) / 1 (ponesimod 6 MG Oral Tablet [Ponvory]) / 1 (ponesimod 7 MG Oral Tablet [Ponvory]) / 1 (ponesimod 8 MG Oral Tablet [Ponvory]) / 1 (ponesimod 9 MG Oral Tablet [Ponvory]) } Pack [Ponvory 14 Day]
BPCK · 2532351 -
Ponesimod 7 MG [Ponvory]
SBDC · 2532340 -
Ponesimod Oral Tablet [Ponvory]
SBDF · 2532308 -
Ponvory Oral Product
SBDG · 2532309 -
Ponvory Pill
SBDG · 2532310 -
Ponvory
BN · 2532306
📦 FDA Products & Package NDCs
4 products · 3 package NDCs
3 package NDCs map to RxCUI 2532339 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43068-0610-09 | 1 KIT in 1 CARTON (43068-610-09) * 1 BLISTER PACK in 1 CAR... | PONVORY | Vanda Pharmaceuticals Inc. | 2024-11-01 |
| 43068-0620-01 | 1 BOTTLE in 1 CARTON (43068-620-01) / 30 TABLET, FILM COATE... | PONVORY | Vanda Pharmaceuticals Inc. | 2024-11-01 |
| 50458-0720-30 | 1 BOTTLE in 1 CARTON (50458-720-30) / 30 TABLET, FILM COATE... | PONVORY | Janssen Pharmaceuticals, Inc | 2021-03-18 |
Observed labelers:
Vanda Pharmaceuticals Inc. (2) ·
Janssen Pharmaceuticals, Inc (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.